US FDA Approves Carboprost Tromethamine Injection by Caplin Steriles

According to Caplin Point Laboratories Ltd., its subsidiary, Caplin Steriles Ltd., has received final FDA approval for carboprost tromethamine injection, which is used to treat postpartum hemorrhage caused by uterine atony. Postpartum hemorrhage, which results in excessive bleeding after delivery, is primarily caused by uterine atony. Carboprost Tromethamine Injection USP, 250 mcg single-dose vials have […]

Continue Reading